Qtick
Sign in

Codexis, Inc. (CDXS) Competitors & Peers

The 5 largest companies in the same industry as Codexis, Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.

as of 2026-09-25

How we identify peers ↗

TickerRelationshipPriceComparables
VRTXPeer$526.19P/E 30.7RSI 53Cap 133.4 B
REGNPeer$788.04P/E 19.5RSI 48Cap 81.1 B
ARGXPeer$959.49P/E 36.5RSI 45Cap 60.0 B
RVMDPeer$204.97RSI 54Cap 43.9 B
ALNYPeer$255.96P/E 44.7RSI 56Cap 34.2 B

How these relationships were derived

Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.

Confirmed relationships (cited)

Sourced from a public filing or disclosure — each links to its origin.

  • ARCHSupplier

    Own 10-Q customer-concentration disclosure: Arch = 0% of revenue.

    Confirmed — SEC filing / public disclosuresec.gov ↗
  • PFESupplier

    Own 10-Q customer-concentration disclosure: Pfizer = 12% of revenue.

    Confirmed — SEC filing / public disclosuresec.gov ↗
  • XELASupplier

    Own 10-K customer-concentration disclosure: ExelaPharmSciInc = 12% of revenue.

    Confirmed — SEC filing / public disclosuresec.gov ↗
  • NESN.SWSupplier

    Own 10-K customer-concentration disclosure: Nestle = 22% of revenue.

    Confirmed — SEC filing / public disclosuresec.gov ↗

Model-inferred relationships (unverified)

Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.

  • IQVPartner

    IQVIA provides contract clinical research and trial management services (CRO).

    Model-inferred, unverified — treat as a lead, not evidence
  • AMZNSupplier

    Utilizes AWS cloud infrastructure to host genomic sequencing data and clinical trial databases.

    Model-inferred, unverified — treat as a lead, not evidence
  • PFECompetitor

    Competes in development and commercialization of therapeutics for similar indications.

    Model-inferred, unverified — treat as a lead, not evidence